WHITEBOX ADVISORS LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
WHITEBOX ADVISORS LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$8,677,750
+1.3%
16,850,000
-4.3%
0.28%
+18.0%
Q2 2023$8,569,440
+5.0%
17,600,000
-14.6%
0.23%
-16.8%
Q1 2023$8,159,660
-22.9%
20,600,000
+5.1%
0.28%
-4.4%
Q4 2022$10,584,000
-0.9%
19,600,0000.0%0.29%
-1.3%
Q3 2022$10,682,000
-1.8%
19,600,000
-2.0%
0.30%
-11.3%
Q2 2022$10,875,000
+2.4%
20,000,000
-4.8%
0.34%
+56.5%
Q1 2022$10,618,000
-9.7%
21,000,000
-6.7%
0.21%
-10.8%
Q4 2021$11,756,00022,500,0000.24%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
Context Capital Management, LLC 18,764$9,907,0000.77%
Pentwater Capital Management LP 46,411,000$24,770,0000.27%
WHITEBOX ADVISORS LLC 22,500,000$11,756,0000.24%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$10,993,0000.23%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 17,590,000$9,286,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$12,540,0000.18%
BlueCrest Capital Management Ltd 7,000,000$3,705,0000.12%
DCF Advisers, LLC 400,000$211,0000.09%
Walleye Capital LLC 5,000$2,638,0000.08%
INGALLS & SNYDER LLC 883,000$461,0000.02%
View complete list of ESPERION THERAPEUTICS INC NE shareholders